Loading…
Anondita Medicare (ANONDITA)₹1,003+0.29%Personal Care
In the Mar 2026 quarter (consolidated), Anondita Medicare reported sales of ₹82.73 Cr, up 80.6% from Mar 2025, and net profit of ₹20.98 Cr, up 110.0% year on year. For the year to Mar 2026, sales were ₹137 Cr and net profit ₹33.96 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 30.89 | 45.80 | 53.83 | 82.73 |
| Expenses | 22.04 | 30.08 | 35.09 | 52.10 |
| Operating Profit | 9.97 | 15.95 | 18.94 | 30.88 |
| OPM % | 31.1% | 35.1% | 35.1% | 38.1% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.99 | 0.99 | 1.99 | 1.99 |
| Depreciation | 0.00 | 0.00 | 0.00 | 1.01 |
| Profit before tax | 7.97 | 13.96 | 16.93 | 29.89 |
| Tax % | 24.9% | 25.9% | 24.9% | 28.0% |
| Net Profit | 5.99 | 9.99 | 12.97 | 20.98 |
| EPS (Rs) | 4.28 | 7.68 | 7.10 | 10.48 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 76.66 | 137 |
| Expenses | 51.13 | 87.17 |
| Operating Profit | 25.91 | 50.80 |
| OPM % | 33.1% | 37.1% |
| Other Income | 0.00 | 1.01 |
| Interest | 2.99 | 3.99 |
| Depreciation | 1.01 | 1.01 |
| Profit before tax | 21.93 | 46.83 |
| Tax % | 24.9% | 27.0% |
| Exceptional items | 0.00 | 0.00 |
| Net Profit | 15.98 | 33.96 |
| EPS (Rs) | 11.89 | 18.50 |
| Dividend payout % | 0.0% | 0.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 12.99 | 17.98 |
| Reserves | 25.06 | 111 |
| Borrowings | 26.96 | 33.94 |
| Other Liabilities | 13.06 | 22.11 |
| Total Liabilities | 78.07 | 185 |
| Fixed Assets | 14.06 | 84.24 |
| CWIP | 6.01 | 0.00 |
| Investments | 2.99 | 0.00 |
| Other Assets | 55.01 | 101 |
| Inventories | 13.98 | 20.97 |
| Trade receivables | 26.96 | 51.94 |
| Cash & equivalents | 0.00 | 10.04 |
| Total Assets | 78.07 | 185 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from operating activity | −9.99 | 10.99 |
| Cash from investing activity | −22.98 | −62.92 |
| Cash from financing activity | 32.98 | 61.02 |
| Net cash flow | 0.00 | 8.99 |
| Capex | 20.04 | 63.18 |
| Free cash flow | −29.98 | −51.95 |
| CFO / OP % | −38.0% | 28.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor days | 128 | 139 |
| Inventory days | 142 | 127 |
| Days payable | 40 | 49 |
| Cash conversion cycle | 228 | 215 |
| Working capital days | 128 | 162 |
| ROCE % | — | 44.0% |
For the Mar 2026 quarter, Anondita Medicare reported sales of ₹82.73 Cr, up 80.6% year on year and net profit of ₹20.98 Cr, up 110.0% year on year. The operating margin was 38.1%.
Anondita Medicare's sales for the year to Mar 2026 were ₹137 Cr.
Net profit for the year to Mar 2026 was ₹33.96 Cr. Earnings per share over the same trailing period were ₹18.50.
Anondita Medicare reported borrowings of ₹33.94 Cr at Mar 2026, against cash and equivalents of ₹10.04 Cr.
Cash from operations was ₹10.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹51.95 Cr.